Канал: CINP

CINP 2024 - Plenary Lecture - Dr. Virginia Man-Yee Lee - Transmission of Misfolded Proteins

CINP 2024 - Plenary Lecture - Dr. Virginia Man-Yee Lee - Transmission of Misfolded Proteins

CINP 2024 - Plenary Lecture - Prof. W. Wolfgang Fleischhacker - Treatment of Schizophrenia

CINP 2024 - Plenary Lecture - Prof. W. Wolfgang Fleischhacker - Treatment of Schizophrenia

CINP 2024 - Plenary Lecture - Prof. Belinda Lennox - Brains on fire?

CINP 2024 - Plenary Lecture - Prof. Belinda Lennox - Brains on fire?

CINP 2024 - Plenary Lecture - Dr Joshua A. Gordon - Challenges and Opportunities

CINP 2024 - Plenary Lecture - Dr Joshua A. Gordon - Challenges and Opportunities

CINP 2024 - Plenary Lecture - Prof. Gabriella Gobbi - Cannabis and Mood Disorders

CINP 2024 - Plenary Lecture - Prof. Gabriella Gobbi - Cannabis and Mood Disorders

CINP 2024 - Plenary Lecture - Dr. Haruo Naito - Spirit of Drug Discovery

CINP 2024 - Plenary Lecture - Dr. Haruo Naito - Spirit of Drug Discovery

CINP 2024 - Plenary Lecture - Dr. George Koob - Alcohol Use Disorder

CINP 2024 - Plenary Lecture - Dr. George Koob - Alcohol Use Disorder

CINP2023 Congress Video - Montreal

CINP2023 Congress Video - Montreal

Dr Asilay Seker - Join us at the 34th CINP World Congress of Neuropsychopharmacology (CINP2023)

Dr Asilay Seker - Join us at the 34th CINP World Congress of Neuropsychopharmacology (CINP2023)

Dr Kazutaka Ikeda - Join us at the 34th CINP World Congress of Neuropsychopharmacology (CINP2023)

Dr Kazutaka Ikeda - Join us at the 34th CINP World Congress of Neuropsychopharmacology (CINP2023)

Prof Pierre Blier - Join us at the 34th CINP World Congress of Neuropsychopharmacology (CINP2023)

Prof Pierre Blier - Join us at the 34th CINP World Congress of Neuropsychopharmacology (CINP2023)

Dr Joseph Zahar - Join us at the 34th CINP World Congress of Neuropsychopharmacology (CINP2023)

Dr Joseph Zahar - Join us at the 34th CINP World Congress of Neuropsychopharmacology (CINP2023)

Dr. Laura Roberts - CINP Ethics Prize Winner

Dr. Laura Roberts - CINP Ethics Prize Winner

Dr. Gabriella Gobbi - CINP Sumitomo/Sunovion Brain Health Basic Research Award Winner

Dr. Gabriella Gobbi - CINP Sumitomo/Sunovion Brain Health Basic Research Award Winner

Dr. Tomas Hökfelt - CINP Pioneer Award Winner Part 1

Dr. Tomas Hökfelt - CINP Pioneer Award Winner Part 1

Dr. Tomas Hökfelt - CINP Pioneer Award Winner Part 2

Dr. Tomas Hökfelt - CINP Pioneer Award Winner Part 2

Dr. Robert McCutcheon - CINP Max Hamilton Memorial Prize Winner

Dr. Robert McCutcheon - CINP Max Hamilton Memorial Prize Winner

Dr. Sameer Jauhar - Rafaelsen Young Investigator Award Winner

Dr. Sameer Jauhar - Rafaelsen Young Investigator Award Winner

Dr. Toshitaka Nabeshima - CINP Pioneer Award Winner

Dr. Toshitaka Nabeshima - CINP Pioneer Award Winner

Yukiko Ochiai - CINP Student Encouragement Award Winner

Yukiko Ochiai - CINP Student Encouragement Award Winner

Dr. Jennifer Phillips - CINP Rafaelsen Young Investigator Award Winner

Dr. Jennifer Phillips - CINP Rafaelsen Young Investigator Award Winner

Peter Stöhrmann - CINP Student Encouragement Award Winner

Peter Stöhrmann - CINP Student Encouragement Award Winner

Dr. Celso Arango - CINP Sumitomo/Sunovion Brain Health Clinical Research Award Winner

Dr. Celso Arango - CINP Sumitomo/Sunovion Brain Health Clinical Research Award Winner

CINP 2022 Business Meeting

CINP 2022 Business Meeting

Debate Part 2 - Konstantinos Fountoulakis - Is Long-Term Treatment with Antipsychotics Justified?

Debate Part 2 - Konstantinos Fountoulakis - Is Long-Term Treatment with Antipsychotics Justified?

Debate Part 1 - Robin Murray - Is Long-Term Treatment with Antipsychotics Justified?

Debate Part 1 - Robin Murray - Is Long-Term Treatment with Antipsychotics Justified?

Clinical Focus & Frontiers 2 - Part 2 - Larry Klassen - ADHD Treatment Implications

Clinical Focus & Frontiers 2 - Part 2 - Larry Klassen - ADHD Treatment Implications

Clinical Focus & Frontiers 2 - Part 1 - Barbara Franke - ADHD: Opportunities for Personized Medicine

Clinical Focus & Frontiers 2 - Part 1 - Barbara Franke - ADHD: Opportunities for Personized Medicine

Clinical Focus & Frontiers 1 - Part 2 - Naomi Fineberg - OCD Therapeutics

Clinical Focus & Frontiers 1 - Part 2 - Naomi Fineberg - OCD Therapeutics

Clinical Focus & Frontiers 1 - Part 1 - Joseph Zohar - Diagnosis of OCD

Clinical Focus & Frontiers 1 - Part 1 - Joseph Zohar - Diagnosis of OCD

Symposium 10 - Part 2 - Novel Molecular and Cellular Mechanisms of Rapid-acting Antidepressant KET

Symposium 10 - Part 2 - Novel Molecular and Cellular Mechanisms of Rapid-acting Antidepressant KET

Symposium 10 - Part 1 - Novel Molecular and Cellular Mechanisms of Rapid-acting Antidepressant KET

Symposium 10 - Part 1 - Novel Molecular and Cellular Mechanisms of Rapid-acting Antidepressant KET

Symposium 9 - Part 2 - Estrogen and Psychiatric Illnesses

Symposium 9 - Part 2 - Estrogen and Psychiatric Illnesses

Symposium 9 - Part 1 - Estrogen and Psychiatric Illnesses

Symposium 9 - Part 1 - Estrogen and Psychiatric Illnesses

Symposium 8 - Part 2 - Gene-Environment Interaction in Schizophrenia

Symposium 8 - Part 2 - Gene-Environment Interaction in Schizophrenia

Symposium 8 - Part 1 - Gene-Environment Interaction in Schizophrenia

Symposium 8 - Part 1 - Gene-Environment Interaction in Schizophrenia

Symposium 7 - Part 2 - Rapid Onset and Sustained Action of Ketamine in Depressive Episodes

Symposium 7 - Part 2 - Rapid Onset and Sustained Action of Ketamine in Depressive Episodes

Symposium 7 - Part 1 - Rapid Onset and Sustained Action of Ketamine in Depressive Episodes

Symposium 7 - Part 1 - Rapid Onset and Sustained Action of Ketamine in Depressive Episodes

Symposium 6 - Part 2 - Treatment Resistant Depression

Symposium 6 - Part 2 - Treatment Resistant Depression

Symposium 6 - Part 1 - Treatment Resistant Depression

Symposium 6 - Part 1 - Treatment Resistant Depression

Symposium 5 - Part 2 - Stronger Together? Using PET and MRI in Neuropsychopharmacology

Symposium 5 - Part 2 - Stronger Together? Using PET and MRI in Neuropsychopharmacology

Symposium 5 - Part 1 - Stronger Together? Using PET and MRI in Neuropsychopharmacology

Symposium 5 - Part 1 - Stronger Together? Using PET and MRI in Neuropsychopharmacology

Symposium 4 - Part 2 - Altered Circadian Rhythms in Psychiatric Mood Disorders: New Treatments

Symposium 4 - Part 2 - Altered Circadian Rhythms in Psychiatric Mood Disorders: New Treatments

Symposium 4 - Part 1 - Altered Circadian Rhythms in Psychiatric Mood Disorders: New Treatments

Symposium 4 - Part 1 - Altered Circadian Rhythms in Psychiatric Mood Disorders: New Treatments

Symposium 3 - Part 2 - Partial Dopamine Agonists:Wide Spectrum Medications for Psychiatric Disorders

Symposium 3 - Part 2 - Partial Dopamine Agonists:Wide Spectrum Medications for Psychiatric Disorders

Symposium 3 - Part 1 - Partial Dopamine Agonists:Wide Spectrum Medications for Psychiatric Disorders

Symposium 3 - Part 1 - Partial Dopamine Agonists:Wide Spectrum Medications for Psychiatric Disorders

Symposium 2 - Part 2 - The Importance of the Muscarinic M1 Receptor in CNS Function

Symposium 2 - Part 2 - The Importance of the Muscarinic M1 Receptor in CNS Function

Symposium 2 - Part 1 - The Importance of the Muscarinic M1 Receptor in CNS Function

Symposium 2 - Part 1 - The Importance of the Muscarinic M1 Receptor in CNS Function

Symposium 1 - Part 2 - Transgender Hormone Therapy: Effects on Brain Structure and Function

Symposium 1 - Part 2 - Transgender Hormone Therapy: Effects on Brain Structure and Function

Symposium 1 - Part 1 - Transgender Hormone Therapy: Effects on Brain Structure and Function

Symposium 1 - Part 1 - Transgender Hormone Therapy: Effects on Brain Structure and Function

PL06 - Gabriella Gobbi - Effects of Cannabis in Adolescence

PL06 - Gabriella Gobbi - Effects of Cannabis in Adolescence

PL05 - Noriko Osumi - Transgenerational Epigenetics: A Key to Understand Neurodevelopmental Diseases

PL05 - Noriko Osumi - Transgenerational Epigenetics: A Key to Understand Neurodevelopmental Diseases

PL04 - Maria Oquendo - Neurobiological and Physiological Consequences of Social Isolation

PL04 - Maria Oquendo - Neurobiological and Physiological Consequences of Social Isolation

PL03 - Tung-Ping Su - Big Data Analyses for Neuropsychopharmacology

PL03 - Tung-Ping Su - Big Data Analyses for Neuropsychopharmacology

PL02 - Josef Penninger - ACE2 – From Discovery to the Centre of a Pandemic

PL02 - Josef Penninger - ACE2 – From Discovery to the Centre of a Pandemic

PL01 - Barbara Franke - From Genes to Clinical Phenotype in ADHD Across the Lifespan

PL01 - Barbara Franke - From Genes to Clinical Phenotype in ADHD Across the Lifespan

CINP 2021 Business Meeting

CINP 2021 Business Meeting

Suicide, Internet Gaming Addiction and ADHD in Adolescents and Adults // CINP Asian Panel - Part 3

Suicide, Internet Gaming Addiction and ADHD in Adolescents and Adults // CINP Asian Panel - Part 3

Polypharmacy in Asia: Differences in Asian Countries // CINP Asian Panel - Part 2

Polypharmacy in Asia: Differences in Asian Countries // CINP Asian Panel - Part 2

New Drugs & New Mechanisms for Treatment Psychotic Disorders // CINP Asian Panel - Part 1

New Drugs & New Mechanisms for Treatment Psychotic Disorders // CINP Asian Panel - Part 1

Noval Therapeutics on Treatment Resistant Bipolar Depression // CINP Member Panel - Part 3

Noval Therapeutics on Treatment Resistant Bipolar Depression // CINP Member Panel - Part 3

How to Treat and Manage Patients with Bipolar Disorder // CINP Member Panel - Part 2

How to Treat and Manage Patients with Bipolar Disorder // CINP Member Panel - Part 2

Definition of Treatment Resistant Bipolar Disorder // CINP Member Panel - Part 1

Definition of Treatment Resistant Bipolar Disorder // CINP Member Panel - Part 1

New Medication for Schizophrenia // CINP Leader Panel - Part 4

New Medication for Schizophrenia // CINP Leader Panel - Part 4

New Treatments for Treatment-Resistant Depression // CINP Leader Panel - Part 3

New Treatments for Treatment-Resistant Depression // CINP Leader Panel - Part 3

Use of Cannabinoids in Psychiatric Patients // CINP Leader Panel - Part 2

Use of Cannabinoids in Psychiatric Patients // CINP Leader Panel - Part 2

Treatment-Resistant Depression // CINP Leader Panel - Part 1

Treatment-Resistant Depression // CINP Leader Panel - Part 1

Pharmacotherapy, Psychotherapy and/or Placebo?// CINP Young Psychiatrist Panel - Part 3

Pharmacotherapy, Psychotherapy and/or Placebo?// CINP Young Psychiatrist Panel - Part 3

Cognitive Dysfunction in Depression // CINP Young Psychiatrist Panel - Part 2

Cognitive Dysfunction in Depression // CINP Young Psychiatrist Panel - Part 2

Measurement and Specific Effects of SSRIs in Depression // CINP Young Psychiatrist Panel - Part 1

Measurement and Specific Effects of SSRIs in Depression // CINP Young Psychiatrist Panel - Part 1

Why attend the 2021 CINP World Congress

Why attend the 2021 CINP World Congress

Neuroscience based Nomenclature - Children & Adolescents

Neuroscience based Nomenclature - Children & Adolescents

NbN2 - Neuroscience based Nomenclature (2nd Edition)

NbN2 - Neuroscience based Nomenclature (2nd Edition)

Long-Acting Injectable Antipsychotics | Shih-Ku Lin

Long-Acting Injectable Antipsychotics | Shih-Ku Lin

Long-Acting Injectable Antipsychotics - An Overview | Konstantinos N. Fountoulakis

Long-Acting Injectable Antipsychotics - An Overview | Konstantinos N. Fountoulakis

Rapid Acting Antidepressants | John Krystal

Rapid Acting Antidepressants | John Krystal

Treatment Resistant Depression - The Scope of the Problem | Siegfried Kasper

Treatment Resistant Depression - The Scope of the Problem | Siegfried Kasper